loadpatents
name:-0.035274982452393
name:-0.033570051193237
name:-0.0018539428710938
REPHAELI; Ada Patent Filings

REPHAELI; Ada

Patent Applications and Registrations

Patent applications and USPTO patent grants for REPHAELI; Ada.The latest application filed is for "compositions and methods for treating sickle cell disease".

Company Profile
1.34.29
  • REPHAELI; Ada - Tel Aviv IL
  • REPHAELI; Ada - Herzelia IL
  • Rephaeli; Ada - Herzlia IL
  • REPHAELI; Ada - Herzliya IL
  • Rephaeli; Ada - North Caldwell NJ
  • Rephaeli; Ada - Palo Alto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and Methods for Treating Sickle Cell Disease
App 20210145783 - PACE; Betty S. ;   et al.
2021-05-20
Butyroyloxymethyl Diethyl Phosphate Compounds And Uses Thereof
App 20170189376 - ELCHARAR; Lilach Moyal ;   et al.
2017-07-06
Nucleoside Analogs And Uses Thereof
App 20160228444 - Rephaeli; Ada ;   et al.
2016-08-11
Derivatives of purinic and pyrimidinic antiviral agents and use thereof as potent anticancer agents
Grant 9,334,272 - Nudelman , et al. May 10, 2
2016-05-10
5-aminolevulinic Acid Derivatives, Methods For Their Preparation And Uses Thereof
App 20150216830 - REPHAELI; Ada ;   et al.
2015-08-06
5-aminolevulinic acid derivatives, methods for their preparation and uses thereof
Grant 9,018,257 - Rephaeli , et al. April 28, 2
2015-04-28
Methods of improving cognitive functions
Grant 8,975,251 - Geffen , et al. March 10, 2
2015-03-10
Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
Grant 8,916,610 - Nudelman , et al. December 23, 2
2014-12-23
Novel Derivatives Of Purinic And Pyrimidinic Antiviral Agents And Use Thereof As Potent Anticancer Agents
App 20140371245 - NUDELMAN; Abraham ;   et al.
2014-12-18
Conjugates for treating neurodegenerative diseases and disorders
Grant 8,722,923 - Stein , et al. May 13, 2
2014-05-13
5-aminolevulinic Acid Derivatives, Methods For Their Preparation And Uses Thereof
App 20140024710 - Rephaeli; Ada ;   et al.
2014-01-23
Acid Addition Salt Of A Nortriptyline-gaba Conjugate And A Process Of Preparing Same
App 20130184347 - Nudelman; Abraham ;   et al.
2013-07-18
Crystalline Forms Of The Tri-mesylate Salt Of Perphenazine-gaba And Process Of Producing The Same
App 20130150352 - NUDELMAN; Abraham ;   et al.
2013-06-13
Conjugates Comprising A Gaba- Or Glycine Compound, Pharmaceutical Compositions And Combinations Thereof As Well As Their Use In Treating Cns Disorders
App 20130059910 - NUDELMAN; Abraham ;   et al.
2013-03-07
Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders
Grant 8,377,990 - Nudelman , et al. February 19, 2
2013-02-19
Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
Grant 8,377,929 - Nudelman , et al. February 19, 2
2013-02-19
Conjugated Psychotropic Drugs And Uses Thereof
App 20120309748 - Nudelman; Abraham ;   et al.
2012-12-06
Novel Conjugates For Treating Neurodegenerative Diseases And Disorders
App 20120277310 - STEIN; Gideon ;   et al.
2012-11-01
Conjugated psychotropic drugs and uses thereof
Grant 8,283,381 - Nudelman , et al. October 9, 2
2012-10-09
Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders
Grant 8,222,296 - Nudelman , et al. July 17, 2
2012-07-17
Conjugates for treating neurodegenerative diseases and disorders
Grant 8,207,369 - Stein , et al. June 26, 2
2012-06-26
Conjugated psychotropic drugs and uses thereof
Grant 8,168,628 - Nudelman , et al. May 1, 2
2012-05-01
Crystalline Forms of the Tri-Mesylate Salt of Perphenazine-Gaba and Process of Producing the Same
App 20110312948 - Nudelman; Abraham ;   et al.
2011-12-22
Methods Of Improving Cognitive Functions
App 20110178073 - GEFFEN; Yona ;   et al.
2011-07-21
Conjugated psychotropic drugs and uses thereof
Grant 7,939,525 - Nudelman , et al. May 10, 2
2011-05-10
Novel Conjugates For Treating Neurodegenerative Diseases And Disorders
App 20110034553 - Stein; Gideon ;   et al.
2011-02-10
Novel Derivatives Of Purinic And Pyrimidinic Antiviral Agents And Use Thereof As Potent Anticancer Agents
App 20110028497 - Nudelman; Abraham ;   et al.
2011-02-03
Conjugated Psychotropic Drugs And Uses Thereof
App 20100204469 - NUDELMAN; Abraham ;   et al.
2010-08-12
Conjugates Comprising a gaba-or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders
App 20100144869 - Nudelman; Abraham ;   et al.
2010-06-10
Conjugated psychotropic drugs and uses thereof
App 20100120755 - Nudelman; Abraham ;   et al.
2010-05-13
Conjugated psychotropic drugs and uses thereof
App 20100063034 - Nudelman; Abraham ;   et al.
2010-03-11
Conjugates Comprising A Gaba- Or Glycine Compound, Pharmaceutical Compositions And Combinations Thereof And Their Use In Treating Cns Disorders
App 20090304584 - Nudelman; Abraham ;   et al.
2009-12-10
Novel salts of conjugated psychotropic drugs and processes of preparing same
App 20090298814 - Nudelman; Abraham ;   et al.
2009-12-03
Conjugated psychotropic drugs and uses thereof
Grant 7,619,006 - Nudelman , et al. November 17, 2
2009-11-17
Conjugated psychotropic drugs and uses thereof
Grant 7,598,239 - Nudelman , et al. October 6, 2
2009-10-06
Conjugated psychotropic drugs and uses thereof
Grant 7,544,681 - Nudelman , et al. June 9, 2
2009-06-09
Conjugated psychotropic drugs and uses thereof
App 20080108606 - Nudelman; Abraham ;   et al.
2008-05-08
Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety
App 20070293517 - Nudelman; Abraham ;   et al.
2007-12-20
Conjugated psychotropic drugs and uses thereof
App 20070197514 - Nudelman; Abraham ;   et al.
2007-08-23
Conjugated psychotropic drugs and uses thereof
App 20070099977 - Nudelman; Abraham ;   et al.
2007-05-03
Conjugated psychotropic drugs and uses thereof
App 20040242570 - Nudelman, Abraham ;   et al.
2004-12-02
Uses of hydroxy and ether-containing oxyalkylene esters for treating metabolic conditions
Grant 6,239,176 - Nudelman , et al. May 29, 2
2001-05-29
Tricarboxylic acid-containing oxyalkyl esters and uses thereof
Grant 6,130,248 - Nudelman , et al. October 10, 2
2000-10-10
Metabolically stabilized oxyalkylene esters and uses thereof
Grant 6,110,955 - Nudelman , et al. August 29, 2
2000-08-29
Nitrogen-containing oxyalkylene esters and uses thereof
Grant 6,110,970 - Nudelman , et al. August 29, 2
2000-08-29
Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
Grant 6,071,923 - Nudelman , et al. June 6, 2
2000-06-06
Hydroxy and ether-containing oxyalkylene esters and uses thereof
Grant 6,043,389 - Nudelman , et al. March 28, 2
2000-03-28
Retinoyloxy (alkyl-substituted) methyl butyrates useful for the treatment of gastrointestinal disorders, cutaneous ulcers and wounds
Grant 6,043,277 - Rephaeli , et al. March 28, 2
2000-03-28
Retinoyloxy (alkyl-substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
Grant 6,040,342 - Rephaeli , et al. March 21, 2
2000-03-21
Oxyalkylene phosphate compounds and uses thereof
Grant 6,030,961 - Nudelman , et al. February 29, 2
2000-02-29
Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives
Grant 5,939,455 - Rephaeli August 17, 1
1999-08-17
Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
Grant 5,710,176 - Rephaeli , et al. January 20, 1
1998-01-20
Methods of using carboxylic acid esters to increase fetal-hemoglobin levels
Grant 5,569,675 - Rephaeli , et al. October 29, 1
1996-10-29
Biologically active carboxylic acid esters
Grant 5,200,553 - Nudelman , et al. April 6, 1
1993-04-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed